300
Participants
Start Date
January 28, 2020
Primary Completion Date
August 21, 2023
Study Completion Date
August 21, 2023
Esomeprazole
"160 mg of esomeprazole will be diluted in 100 ml of 0.9% sodium chloride for intravenous use for bolus.~For continuous intravenous infusion, 40 mg of esomeprazole will be reconstituted by adding 5 ml of 0.9% sodium chloride for intravenous use at a concentration of 8 mg/ml."
Placebo
0.9% sodium chloride (same ml of the study drug)
Humanitas Clinical Institute, Rozzano
IRCCS San Raffaele Scientific Institute, Milan
Policlinico Univeristario Campus Bio-Medico, Rome
IRCCS San Martino Istitute, Genoa
A.O.U. Mater Domini, Catanzaro
Azienda Ospedaliera Universitaria, Cagliari
USSL 10 Veneto, San Donà di Piave
Ospedale Maggiore di Lodi, Lodi
Ospedale di Merano, Merano
"Università degli Studi della Campania Luigi Vanvitelli", Napoli
AOU Pisana, Pisa
A.O.R San Carlo, Potenza
Azienda Ospedaliera San Giovanni Battista Molinette di Torino, Torino
Ospedale Santa Maria della Misericordia, Udine
Astana Medical University, Kazakhstan
Federal Clinical & Research Center for Reanimatology and Rehabilitation, Moscow
Negovskiy Reanimatology Research Institute, Moscow
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
OTHER
Università Vita-Salute San Raffaele
OTHER